Market Access News | pharmaphorum

News

AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available.

News

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there.

News

Sun Pharma successfully removed an injunction on the launch of its Leqselvi for alopecia areata, a common form of hair loss, in the US.

News

The first targeted drug for a common form of bladder cancer that can be taken at home. J&J's Balversa, has been backed for NHS use.

News

The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of colorectal cancer.

News

Pharma leaders have told the EU that without reforms the bloc could lose out on major capital investment programmes and R&D spending.